Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1858 ARTÍCULOS , VIENDO DEL 256 AL 270
Metabolic profiling in the arena of gut-brain interaction studies for Alzheimer's disease
Olga D, Helen GG.
Bioanalysis. 2020 Apr;12(8):501-504. doi: 10.4155/bio-2020-0066. Epub 2020 Apr 30.
Calcium-activated potassium channels: implications for aging and age-related neurodegeneration
Trombetta-Lima M, Krabbendam IE, Dolga AM.
Int J Biochem Cell Biol. 2020 Jun;123:105748. doi: 10.1016/j.biocel.2020.105748. Epub 2020 Apr 27.
Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease
Uddin MS, Kabir MT, Mamun AA, Barreto GE, Rashid M, Perveen A, Ashraf GM.
Int Immunopharmacol. 2020 Jul;84:106479. doi: 10.1016/j.intimp.2020.106479. Epub 2020 Apr 27.
Successive cleavage of β-amyloid precursor protein by γ-secretase
Funamoto S, Tagami S, Okochi M, Morishima-Kawashima M.
Semin Cell Dev Biol. 2020 Sep;105:64-74. doi: 10.1016/j.semcdb.2020.04.002. Epub 2020 Apr 27.
The MUC6/AP2A2 Locus and Its Relevance to Alzheimer's Disease: A Review
Nelson PT, Fardo DW, Katsumata Y.
J Neuropathol Exp Neurol. 2020 Jun 1;79(6):568-584. doi: 10.1093/jnen/nlaa024.
Karaca O, Buyukmert A, Tepe N, Ozcan E, Kus I.
J Clin Neurosci. 2020 Aug;78:333-338. doi: 10.1016/j.jocn.2020.04.092. Epub 2020 Apr 29.
Tau immunotherapies: Lessons learned, current status and future considerations
Sandusky-Beltran LA, Sigurdsson EM.
Neuropharmacology. 2020 Sep 15;175:108104. doi: 10.1016/j.neuropharm.2020.108104. Epub 2020 Apr 28.
The current landscape in Alzheimer's disease research and drug discovery
Devenish SRA.
Drug Discov Today. 2020 Jun;25(6):943-945. doi: 10.1016/j.drudis.2020.04.002. Epub 2020 Apr 28.
Alzheimer's Disease and Functional Foods: An Insight on Neuroprotective Effect of its Combination
Hasnieza Mohd Rosli N, Mastura Yahya H, Shahar S, Wahida Ibrahim F, Fadilah Rajab N.
Pak J Biol Sci. 2020 Jan;23(5):575-589. doi: 10.3923/pjbs.2020.575.589.
Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease
Amponsah AE, Feng B, Guo R, Zhang W, He J, Kong D, Dong T, Ma J, Cui H.
Rev Neurosci. 2020 Aug 27;31(6):589-603. doi: 10.1515/revneuro-2019-0115.
Type 3 Diabetes and Its Role Implications in Alzheimer's Disease
Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV.
Int J Mol Sci. 2020 Apr 30;21(9):3165. doi: 10.3390/ijms21093165.
Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.
Int J Mol Sci. 2020 Apr 30;21(9):3186. doi: 10.3390/ijms21093186.
Munter LM.
J Neurochem. 2020 Jul;154(1):7-10. doi: 10.1111/jnc.15025. Epub 2020 May 6.
Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.
Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.
Epilepsy and Alzheimer's Disease: Potential mechanisms for an association
Giorgi FS, Saccaro LF, Busceti CL, Biagioni F, Fornai F.
Brain Res Bull. 2020 Jul;160:107-120. doi: 10.1016/j.brainresbull.2020.04.009. Epub 2020 May 5.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.